# Trends in Venture Capital Investment in AI-Driven Biopharmaceutical Startups

**Authors:** Abhishek Bazaz, Yunan Ji, Mariana P Socal, So-Yeon Kang

PMC · DOI: 10.2196/84968 · Journal of Medical Internet Research · 2026-02-25

## TL;DR

This paper examines how venture capital funding for AI-based biopharma startups has grown rapidly, especially in the US.

## Contribution

The study provides a detailed analysis of global VC investment trends in AI-driven biopharmaceutical startups from 2010 to 2024.

## Key findings

- There has been rapid growth in investments in AI discovery tools.
- Venture capital funding is heavily concentrated in California and Massachusetts.
- The US dominates global investment in this sector.

## Abstract

This study analyzes 2010-2024 venture capital trends in international artificial intelligence–driven biopharmaceutical startups, revealing rapid growth in discovery tool investments and concentrated US funding in California and Massachusetts.

## Full-text entities

- **Diseases:** VC (MESH:D060048), COVID-19 (MESH:D000086382), AI (MESH:C538142)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12980058/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12980058/full.md

## References

10 references — full list in the complete paper: https://tomesphere.com/paper/PMC12980058/full.md

---
Source: https://tomesphere.com/paper/PMC12980058